The Asian Fund for Cancer Research and the U.S.-based National Foundation for Cancer Research recently collaborated in an unprecedented manner, with both organizations gathering together. A first-of-its kind partnership, the Joint NFCR and AFCR Scientific Symposium on Cancer Research and Global Collaboration was held in the U.S. state of Maryland…...
Imaging tumor stiffness could help enhance treatment for breast and pancreatic cancer
Using a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about cancer architecture and could aid the delivery of treatment to the most challenging tumours, new research shows. Magnetic resonance elastography was able to visualise and measure how stiff and dense tumours are in mice.…...
USCACA & AFCR 2019 Scholar Awards
The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2019 Scholar Awards. The Awards will recognize two to three junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research. Candidacy is open to all Chinese researchers who were trained…...
Quest for new cancer treatment crosses milestone
A cancer therapy invented at Rice University has crossed a milestone in clinical trials, a major development in a decades long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation. According to the study, thirteen of the first 15 prostate cancer…...
Tasmanian devil research could help tackle immunotherapy resistance
A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system. This early work in cells could one day guide us towards new drug combinations that improve the effectiveness of immunotherapy treatments. Researchers at…...
Scientists evaluate cancer risk of US drinking water
Researchers from the Environmental Working Group (EWG) in Washington, DC, used a new approach to analyze cumulative cancer risk due to carcinogens in tap water across the U.S. This study is the first to apply a “cumulative cancer risk framework” to the analysis of tap water contaminants for the whole of the U.S.…...
Breakthrough in understanding enzymes that make antibiotic for drug-resistant pathogen
Acinetobacter baumannii is a pathogen that causes hospital-acquired infections that are very difficult to treat, because they are resistant to most currently available antibiotics. As one of the World Health Organization’s three critical priority pathogens, new antibiotics for Acinetobacter baumannii are urgently needed, and is now one step closer to being tackled, as…...
Disparities in toxic heavy metal exposures correlated with increased risk of breast cancer among minority populations
Among women in Chicago, African Americans and Hispanics were exposed to higher levels of ambient toxic heavy metals compared with non-Hispanic whites, and this increased exposure correlated with increased incidence of breast cancer. Garth Rauscher, Ph.D., associate professor of epidemiology at the University of Illinois at Chicago School of Public…...
Discovery of how colorectal cancer drug works will help more patients
Some colorectal cancer patients with a certain gene mutation benefit from a chemotherapy drug called cetuximab, although the mechanism of how this drug worked was unknown. Scientists have combined computational biology with experimental investigations to discover, for the first time, the mechanism for why these patients respond to the drug,…...
BRACE Program Launched by Asian Fund for Cancer Research
FOR IMMEDIATE RELEASE: September 23, 2019 CONTACTS: Asian Fund for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: [email protected] Hugill & Ip Solicitors Marco Raccuia, Operations & Marketing Specialist E-mail: [email protected] Inaugural BRACE Award Competition winner F. Joel Leong, flanked…...
